GW7647 and Rosiglitazone treated human differentiated adipocytes
Ontology highlight
ABSTRACT: Objective : This work aimed at characterizing PPARα involvement in metabolism regulation and at comparing PPARα and PPARγ roles in human white adipocytes. Research Design and Methods : Profiling of gene expression alterations was assessed with microarrays and RT-qPCR. Primary cultures of human adipocytes were treated with PPARα agonist GW7647 or PPARγ agonist Rosiglitazone. Western blot were used to determine protein level modifications. Metabolic changes were evaluated with palmitate and glucose oxidation studies and with metabolite measurements. Results : GW7647 induces an upregulation of β-oxidation gene expression and increases palmitate oxidation. Unexpectedly glycolysis was strongly reduced at transcriptional and functional levels by GW7647 while the overall glucose oxidation remains
ORGANISM(S): Homo sapiens
SUBMITTER: Nathalie Viguerie
PROVIDER: E-GEOD-15862 | biostudies-arrayexpress |
REPOSITORIES: biostudies-arrayexpress
ACCESS DATA